Mechanistic design, translational challenges, and future perspectives of multi-drug nanoparticle-based dry powder inhalers for pulmonary therapy

Sahand Mazloum-Ravasan, Hamed Hamishehkar

Open source

DOI
10.1016/j.ijpharm.2026.127493
Published
2026-12
Container
International Journal of Pharmaceutics
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ijpharm.2026.127493,
  title = {Mechanistic design, translational challenges, and future perspectives of multi-drug nanoparticle-based dry powder inhalers for pulmonary therapy},
  author = {Sahand Mazloum-Ravasan and Hamed Hamishehkar},
  year = {2026},
  journal = {International Journal of Pharmaceutics},
  doi = {10.1016/j.ijpharm.2026.127493},
  url = {https://doi.org/10.1016/j.ijpharm.2026.127493}
}

RIS

TY  - JOUR
TI  - Mechanistic design, translational challenges, and future perspectives of multi-drug nanoparticle-based dry powder inhalers for pulmonary therapy
AU  - Sahand Mazloum-Ravasan
AU  - Hamed Hamishehkar
PY  - 2026
JO  - International Journal of Pharmaceutics
DO  - 10.1016/j.ijpharm.2026.127493
UR  - https://doi.org/10.1016/j.ijpharm.2026.127493
ER  - 

APA

Mazloum-Ravasan, S., & Hamishehkar, H. (2026). Mechanistic design, translational challenges, and future perspectives of multi-drug nanoparticle-based dry powder inhalers for pulmonary therapy. International Journal of Pharmaceutics. https://doi.org/10.1016/j.ijpharm.2026.127493

Source records